nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SIGMAR1—amyotrophic lateral sclerosis	0.673	1	CbGaD
Amantadine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0415	CcSEcCtD
Amantadine—GRIN2C—nerve—amyotrophic lateral sclerosis	0.00467	0.0548	CbGeAlD
Amantadine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0386	CcSEcCtD
Amantadine—GRIN2B—nerve—amyotrophic lateral sclerosis	0.00369	0.0434	CbGeAlD
Amantadine—GRIN2C—hindbrain—amyotrophic lateral sclerosis	0.0035	0.0411	CbGeAlD
Amantadine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0293	CcSEcCtD
Amantadine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0293	CcSEcCtD
Amantadine—GRIN2D—hindbrain—amyotrophic lateral sclerosis	0.00325	0.0382	CbGeAlD
Amantadine—GRIN2A—nerve—amyotrophic lateral sclerosis	0.00323	0.0379	CbGeAlD
Amantadine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0279	CcSEcCtD
Amantadine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00312	0.027	CcSEcCtD
Amantadine—DDC—nerve—amyotrophic lateral sclerosis	0.00301	0.0354	CbGeAlD
Amantadine—GRIN1—hindbrain—amyotrophic lateral sclerosis	0.0029	0.034	CbGeAlD
Amantadine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0243	CcSEcCtD
Amantadine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0241	CcSEcCtD
Amantadine—GRIN2B—hindbrain—amyotrophic lateral sclerosis	0.00276	0.0325	CbGeAlD
Amantadine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0232	CcSEcCtD
Amantadine—Mania—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0226	CcSEcCtD
Amantadine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00254	0.022	CcSEcCtD
Amantadine—GRIN2A—hindbrain—amyotrophic lateral sclerosis	0.00242	0.0284	CbGeAlD
Amantadine—DDC—hindbrain—amyotrophic lateral sclerosis	0.00226	0.0265	CbGeAlD
Amantadine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0191	CcSEcCtD
Amantadine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0175	CcSEcCtD
Amantadine—GRIN2C—brainstem—amyotrophic lateral sclerosis	0.002	0.0235	CbGeAlD
Amantadine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.002	0.0174	CcSEcCtD
Amantadine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0168	CcSEcCtD
Amantadine—GRIN2D—brainstem—amyotrophic lateral sclerosis	0.00186	0.0219	CbGeAlD
Amantadine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0158	CcSEcCtD
Amantadine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0158	CcSEcCtD
Amantadine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00173	0.015	CcSEcCtD
Amantadine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0146	CcSEcCtD
Amantadine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0144	CcSEcCtD
Amantadine—GRIN1—brainstem—amyotrophic lateral sclerosis	0.00166	0.0195	CbGeAlD
Amantadine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0142	CcSEcCtD
Amantadine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0141	CcSEcCtD
Amantadine—GRIN2B—brainstem—amyotrophic lateral sclerosis	0.00158	0.0186	CbGeAlD
Amantadine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0136	CcSEcCtD
Amantadine—MAOB—nerve—amyotrophic lateral sclerosis	0.00155	0.0182	CbGeAlD
Amantadine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0133	CcSEcCtD
Amantadine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0131	CcSEcCtD
Amantadine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0128	CcSEcCtD
Amantadine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0127	CcSEcCtD
Amantadine—DDC—embryo—amyotrophic lateral sclerosis	0.00141	0.0166	CbGeAlD
Amantadine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0122	CcSEcCtD
Amantadine—GRIN2C—medulla oblongata—amyotrophic lateral sclerosis	0.0014	0.0164	CbGeAlD
Amantadine—GRIN2A—brainstem—amyotrophic lateral sclerosis	0.00139	0.0163	CbGeAlD
Amantadine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0119	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0118	CcSEcCtD
Amantadine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0116	CcSEcCtD
Amantadine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0113	CcSEcCtD
Amantadine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0113	CcSEcCtD
Amantadine—DRD2—nerve—amyotrophic lateral sclerosis	0.00131	0.0154	CbGeAlD
Amantadine—GRIN2D—medulla oblongata—amyotrophic lateral sclerosis	0.0013	0.0153	CbGeAlD
Amantadine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0112	CcSEcCtD
Amantadine—DDC—brainstem—amyotrophic lateral sclerosis	0.00129	0.0152	CbGeAlD
Amantadine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00127	0.011	CcSEcCtD
Amantadine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0109	CcSEcCtD
Amantadine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0103	CcSEcCtD
Amantadine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00116	0.0136	CbGeAlD
Amantadine—GRIN2D—spinal cord—amyotrophic lateral sclerosis	0.00116	0.0136	CbGeAlD
Amantadine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00963	CcSEcCtD
Amantadine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0094	CcSEcCtD
Amantadine—GRIN2C—nervous system—amyotrophic lateral sclerosis	0.00105	0.0123	CbGeAlD
Amantadine—GRIN1—spinal cord—amyotrophic lateral sclerosis	0.00103	0.0121	CbGeAlD
Amantadine—GRIN2C—central nervous system—amyotrophic lateral sclerosis	0.00101	0.0119	CbGeAlD
Amantadine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00099	0.00857	CcSEcCtD
Amantadine—GRIN2C—cerebellum—amyotrophic lateral sclerosis	0.000988	0.0116	CbGeAlD
Amantadine—GRIN2B—spinal cord—amyotrophic lateral sclerosis	0.000985	0.0116	CbGeAlD
Amantadine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00098	0.0115	CbGeAlD
Amantadine—GRIN2D—nervous system—amyotrophic lateral sclerosis	0.000976	0.0115	CbGeAlD
Amantadine—GRIN2A—medulla oblongata—amyotrophic lateral sclerosis	0.000966	0.0113	CbGeAlD
Amantadine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000947	0.0082	CcSEcCtD
Amantadine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00094	0.00814	CcSEcCtD
Amantadine—GRIN2D—central nervous system—amyotrophic lateral sclerosis	0.00094	0.011	CbGeAlD
Amantadine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00812	CcSEcCtD
Amantadine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00808	CcSEcCtD
Amantadine—GRIN2D—cerebellum—amyotrophic lateral sclerosis	0.000919	0.0108	CbGeAlD
Amantadine—GRIN3A—nervous system—amyotrophic lateral sclerosis	0.000918	0.0108	CbGeAlD
Amantadine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00089	0.0077	CcSEcCtD
Amantadine—GRIN3A—central nervous system—amyotrophic lateral sclerosis	0.000884	0.0104	CbGeAlD
Amantadine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000884	0.00765	CcSEcCtD
Amantadine—GRIN1—nervous system—amyotrophic lateral sclerosis	0.00087	0.0102	CbGeAlD
Amantadine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000864	0.00748	CcSEcCtD
Amantadine—GRIN2A—spinal cord—amyotrophic lateral sclerosis	0.000861	0.0101	CbGeAlD
Amantadine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000858	0.00743	CcSEcCtD
Amantadine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000851	0.00736	CcSEcCtD
Amantadine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00728	CcSEcCtD
Amantadine—GRIN1—central nervous system—amyotrophic lateral sclerosis	0.000838	0.00984	CbGeAlD
Amantadine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00722	CcSEcCtD
Amantadine—GRIN2B—nervous system—amyotrophic lateral sclerosis	0.00083	0.00975	CbGeAlD
Amantadine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00717	CcSEcCtD
Amantadine—GRIN1—cerebellum—amyotrophic lateral sclerosis	0.000819	0.00962	CbGeAlD
Amantadine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00704	CcSEcCtD
Amantadine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00697	CcSEcCtD
Amantadine—GRIN2C—brain—amyotrophic lateral sclerosis	0.000803	0.00943	CbGeAlD
Amantadine—GRIN2B—central nervous system—amyotrophic lateral sclerosis	0.000799	0.00939	CbGeAlD
Amantadine—GRIN2B—cerebellum—amyotrophic lateral sclerosis	0.000781	0.00918	CbGeAlD
Amantadine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000777	0.00672	CcSEcCtD
Amantadine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000762	0.00659	CcSEcCtD
Amantadine—GRIN2D—brain—amyotrophic lateral sclerosis	0.000746	0.00877	CbGeAlD
Amantadine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00642	CcSEcCtD
Amantadine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000732	0.00634	CcSEcCtD
Amantadine—MAOB—embryo—amyotrophic lateral sclerosis	0.000726	0.00853	CbGeAlD
Amantadine—GRIN2A—nervous system—amyotrophic lateral sclerosis	0.000726	0.00852	CbGeAlD
Amantadine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000718	0.00622	CcSEcCtD
Amantadine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00619	CcSEcCtD
Amantadine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000703	0.00609	CcSEcCtD
Amantadine—GRIN3A—brain—amyotrophic lateral sclerosis	0.000702	0.00824	CbGeAlD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00607	CcSEcCtD
Amantadine—GRIN2A—central nervous system—amyotrophic lateral sclerosis	0.000699	0.00821	CbGeAlD
Amantadine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00597	CcSEcCtD
Amantadine—GRIN2A—cerebellum—amyotrophic lateral sclerosis	0.000683	0.00802	CbGeAlD
Amantadine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000682	0.0059	CcSEcCtD
Amantadine—DDC—nervous system—amyotrophic lateral sclerosis	0.000678	0.00796	CbGeAlD
Amantadine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00586	CcSEcCtD
Amantadine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00586	CcSEcCtD
Amantadine—MAOB—brainstem—amyotrophic lateral sclerosis	0.000666	0.00782	CbGeAlD
Amantadine—GRIN1—brain—amyotrophic lateral sclerosis	0.000665	0.00781	CbGeAlD
Amantadine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00574	CcSEcCtD
Amantadine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00572	CcSEcCtD
Amantadine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00569	CcSEcCtD
Amantadine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000654	0.00566	CcSEcCtD
Amantadine—DDC—central nervous system—amyotrophic lateral sclerosis	0.000653	0.00767	CbGeAlD
Amantadine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000645	0.00558	CcSEcCtD
Amantadine—GRIN2B—brain—amyotrophic lateral sclerosis	0.000635	0.00745	CbGeAlD
Amantadine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00547	CcSEcCtD
Amantadine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000612	0.0053	CcSEcCtD
Amantadine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00526	CcSEcCtD
Amantadine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000603	0.00522	CcSEcCtD
Amantadine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00521	CcSEcCtD
Amantadine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000595	0.00515	CcSEcCtD
Amantadine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00509	CcSEcCtD
Amantadine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000584	0.00506	CcSEcCtD
Amantadine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00505	CcSEcCtD
Amantadine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00501	CcSEcCtD
Amantadine—DRD2—brainstem—amyotrophic lateral sclerosis	0.000562	0.0066	CbGeAlD
Amantadine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000557	0.00483	CcSEcCtD
Amantadine—GRIN2A—brain—amyotrophic lateral sclerosis	0.000555	0.00651	CbGeAlD
Amantadine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000535	0.00463	CcSEcCtD
Amantadine—DDC—brain—amyotrophic lateral sclerosis	0.000518	0.00609	CbGeAlD
Amantadine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00431	CcSEcCtD
Amantadine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000485	0.0042	CcSEcCtD
Amantadine—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000485	0.0057	CbGeAlD
Amantadine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00414	CcSEcCtD
Amantadine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000464	0.00545	CbGeAlD
Amantadine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00401	CcSEcCtD
Amantadine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00387	CcSEcCtD
Amantadine—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000432	0.00508	CbGeAlD
Amantadine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00372	CcSEcCtD
Amantadine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00369	CcSEcCtD
Amantadine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000426	0.00369	CcSEcCtD
Amantadine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00367	CcSEcCtD
Amantadine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000414	0.00486	CbGeAlD
Amantadine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00348	CcSEcCtD
Amantadine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000394	0.00463	CbGeAlD
Amantadine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00038	0.00446	CbGeAlD
Amantadine—MAOB—nervous system—amyotrophic lateral sclerosis	0.000349	0.0041	CbGeAlD
Amantadine—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000343	0.00403	CbGeAlD
Amantadine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000336	0.00394	CbGeAlD
Amantadine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000328	0.00386	CbGeAlD
Amantadine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000301	0.00354	CbGeAlD
Amantadine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000294	0.00346	CbGeAlD
Amantadine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000283	0.00333	CbGeAlD
Amantadine—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000279	0.00327	CbGeAlD
Amantadine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000277	0.00325	CbGeAlD
Amantadine—MAOB—brain—amyotrophic lateral sclerosis	0.000267	0.00313	CbGeAlD
Amantadine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000265	0.00311	CbGeAlD
Amantadine—DRD2—brain—amyotrophic lateral sclerosis	0.000225	0.00264	CbGeAlD
Amantadine—GRIN1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000223	0.00176	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000217	0.00171	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000212	0.00167	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00021	0.00166	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00021	0.00166	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00021	0.00166	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000206	0.00163	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000203	0.0016	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000202	0.00159	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000201	0.00159	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000199	0.00157	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000197	0.00155	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000197	0.00155	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000194	0.00153	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000193	0.00152	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000192	0.00152	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000192	0.00151	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000192	0.00151	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000188	0.00148	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000186	0.00147	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000183	0.00145	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000179	0.00141	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000177	0.0014	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000176	0.00139	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000175	0.00138	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000173	0.00136	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000173	0.00136	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000173	0.00136	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000171	0.00135	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000171	0.00135	CbGpPWpGaD
Amantadine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000169	0.00199	CbGeAlD
Amantadine—GRIN1—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000168	0.00133	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000164	0.00129	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000163	0.00128	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000162	0.00128	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.00016	0.00127	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000158	0.00125	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000155	0.00122	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000154	0.00121	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000152	0.0012	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000152	0.0012	CbGpPWpGaD
Amantadine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000151	0.00177	CbGeAlD
Amantadine—GRIN1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000151	0.00119	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000151	0.00119	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000149	0.00118	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000148	0.00117	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000147	0.00116	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000147	0.00116	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000144	0.00114	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000135	0.00106	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000134	0.00106	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000132	0.00104	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000131	0.00103	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000129	0.00102	CbGpPWpGaD
Amantadine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000127	0.00149	CbGeAlD
Amantadine—SLC22A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000126	0.000992	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000125	0.000982	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000124	0.000979	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000123	0.000966	CbGpPWpGaD
Amantadine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000122	0.00144	CbGeAlD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00012	0.000948	CbGpPWpGaD
Amantadine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00012	0.00141	CbGeAlD
Amantadine—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000117	0.000922	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000116	0.000915	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000112	0.000884	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00011	0.000867	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000109	0.000857	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000107	0.000843	CbGpPWpGaD
Amantadine—DDC—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000106	0.000839	CbGpPWpGaD
Amantadine—DDC—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000106	0.000839	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000106	0.000836	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000104	0.000822	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000103	0.000815	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000103	0.000812	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000103	0.000809	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000102	0.000806	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000102	0.000806	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	9.75e-05	0.000769	CbGpPWpGaD
Amantadine—DDC—Metabolism—VAPA—amyotrophic lateral sclerosis	9.73e-05	0.000767	CbGpPWpGaD
Amantadine—ABCB1—brain—amyotrophic lateral sclerosis	9.72e-05	0.00114	CbGeAlD
Amantadine—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	9.63e-05	0.00076	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	9.57e-05	0.000755	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	9.54e-05	0.000752	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	9.53e-05	0.000752	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	9.53e-05	0.000752	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	9.21e-05	0.000727	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	9.11e-05	0.000719	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	9.09e-05	0.000717	CbGpPWpGaD
Amantadine—DDC—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.04e-05	0.000713	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	8.99e-05	0.000709	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	8.95e-05	0.000706	CbGpPWpGaD
Amantadine—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	8.95e-05	0.000706	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	8.89e-05	0.000701	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	8.79e-05	0.000693	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	8.59e-05	0.000677	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	8.57e-05	0.000676	CbGpPWpGaD
Amantadine—DDC—Metabolism—FIG4—amyotrophic lateral sclerosis	8.5e-05	0.000671	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	8.49e-05	0.00067	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	8.43e-05	0.000665	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	8.35e-05	0.000659	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	8.29e-05	0.000654	CbGpPWpGaD
Amantadine—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	8.19e-05	0.000646	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	7.93e-05	0.000626	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	7.89e-05	0.000622	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	7.86e-05	0.00062	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	7.85e-05	0.00062	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	7.83e-05	0.000618	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	7.83e-05	0.000618	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	7.75e-05	0.000612	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	7.73e-05	0.000609	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	7.69e-05	0.000607	CbGpPWpGaD
Amantadine—DDC—Metabolism—DAO—amyotrophic lateral sclerosis	7.69e-05	0.000607	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.69e-05	0.000606	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.61e-05	0.0006	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	7.59e-05	0.000598	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	7.39e-05	0.000583	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	7.33e-05	0.000578	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	7.33e-05	0.000578	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	7.3e-05	0.000576	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	7.3e-05	0.000576	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	7.22e-05	0.000569	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	7.21e-05	0.000568	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.16e-05	0.000565	CbGpPWpGaD
Amantadine—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	7.16e-05	0.000565	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	6.98e-05	0.000551	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	6.89e-05	0.000543	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	6.85e-05	0.000541	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	6.68e-05	0.000527	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	6.61e-05	0.000521	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	6.51e-05	0.000513	CbGpPWpGaD
Amantadine—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	6.47e-05	0.000511	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	6.44e-05	0.000508	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	6.31e-05	0.000497	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	6.2e-05	0.000489	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	6.12e-05	0.000483	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLB1—amyotrophic lateral sclerosis	5.83e-05	0.00046	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	5.8e-05	0.000457	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSR—amyotrophic lateral sclerosis	5.38e-05	0.000424	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.26e-05	0.000415	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	5.13e-05	0.000404	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	5.04e-05	0.000398	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	4.97e-05	0.000392	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.95e-05	0.000391	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.91e-05	0.000387	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.89e-05	0.000386	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.8e-05	0.000379	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.75e-05	0.000375	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.75e-05	0.000375	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.62e-05	0.000364	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	4.6e-05	0.000363	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	4.53e-05	0.000357	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.43e-05	0.000349	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.43e-05	0.000349	CbGpPWpGaD
Amantadine—DDC—Metabolism—CHAT—amyotrophic lateral sclerosis	4.42e-05	0.000348	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.34e-05	0.000343	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.21e-05	0.000332	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.21e-05	0.000332	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.2e-05	0.000331	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.05e-05	0.000319	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.04e-05	0.000319	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.93e-05	0.00031	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.93e-05	0.00031	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.8e-05	0.0003	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	3.78e-05	0.000298	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.76e-05	0.000297	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.75e-05	0.000296	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.72e-05	0.000293	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.56e-05	0.000281	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.54e-05	0.000279	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.5e-05	0.000276	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.46e-05	0.000273	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.43e-05	0.000271	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.27e-05	0.000258	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.2e-05	0.000253	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.18e-05	0.000251	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.04e-05	0.000239	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3e-05	0.000236	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.97e-05	0.000235	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.93e-05	0.000231	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.86e-05	0.000226	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.86e-05	0.000225	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.75e-05	0.000217	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.71e-05	0.000214	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.71e-05	0.000213	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.6e-05	0.000205	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.6e-05	0.000205	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.6e-05	0.000205	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.58e-05	0.000203	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.46e-05	0.000194	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.43e-05	0.000191	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.4e-05	0.000189	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-05	0.000187	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.37e-05	0.000187	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.33e-05	0.000184	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.3e-05	0.000181	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.3e-05	0.000181	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.27e-05	0.000179	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.24e-05	0.000177	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.21e-05	0.000174	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.000172	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.1e-05	0.000165	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.09e-05	0.000165	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.000164	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.05e-05	0.000162	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.04e-05	0.000161	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2e-05	0.000158	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.000156	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.95e-05	0.000153	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.92e-05	0.000152	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.88e-05	0.000148	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.84e-05	0.000145	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.84e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.81e-05	0.000142	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000142	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.71e-05	0.000135	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.66e-05	0.000131	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.61e-05	0.000127	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	1.51e-05	0.000119	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.5e-05	0.000118	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.49e-05	0.000117	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.47e-05	0.000116	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.46e-05	0.000115	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.000112	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	0.000104	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.27e-05	0.0001	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-05	9.7e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	9.6e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.18e-05	9.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.08e-05	8.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.08e-05	8.48e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	8.36e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.04e-05	8.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1e-05	7.89e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.88e-06	7.79e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.74e-06	7.69e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.6e-06	7.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.38e-06	7.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.08e-06	7.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.93e-06	7.05e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.02e-06	6.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.65e-06	6.03e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.47e-06	5.89e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.19e-06	5.67e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.35e-06	5.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.92e-06	4.67e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.79e-06	4.57e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.49e-06	4.33e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.32e-06	4.2e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.12e-06	4.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.89e-06	3.86e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.38e-06	3.45e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.76e-06	2.97e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.56e-06	2.8e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.19e-06	2.52e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3e-06	2.37e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.41e-06	1.9e-05	CbGpPWpGaD
